DICICCO WENDY F
Insider CIK 1225165 · GDHC Director · SWKH Director · EYPT Director · AKTX Interim CFO · RCOR Interim CFO · IIVI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EYPT EyePoint, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2025-01-03 | 2025-01-07 | 40,000 | — | $0 | 40,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | P Buy | 2024-08-20 | 2024-08-21 | 2,567 | $7.79 | $20.0K | 9,967 | SEC↗ |
| AKTX Akari Therapeutics Plc | A Award | 2024-05-01 | 2024-05-03 | 158,473,915 | — | $0 | 158,473,915 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2024-01-05 | 2024-01-09 | 25,014 | — | $0 | 25,014 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2023-06-20 | 2023-06-22 | 26,100 | — | $0 | 26,100 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2023-06-20 | 2023-06-22 | 13,000 | — | $0 | 13,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2023-02-09 | 2023-02-13 | 3,000 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2023-02-09 | 2023-02-13 | 3,000 | — | $0 | 7,400 | SEC↗ |
| SWKH SWK Holdings Corp | A Award | 2022-12-30 | 2023-01-04 | 779 | $17.64 | $13.7K | 6,182 | SEC↗ |
| SWKH SWK Holdings Corp | A Award | 2022-12-30 | 2023-01-04 | 1,120 | $17.64 | $19.8K | 5,403 | SEC↗ |
| RCOR Renovacor, Inc. | D To issuer deriv | 2022-12-01 | 2022-12-05 | 155,325 | — | $0 | 0 | SEC↗ |
| RCOR Renovacor, Inc. | D To issuer deriv | 2022-12-01 | 2022-12-05 | 37,575 | — | $0 | 0 | SEC↗ |
| RCOR Renovacor, Inc. | D To issuer deriv | 2022-12-01 | 2022-12-05 | 14,553 | — | $0 | 0 | SEC↗ |
| RCOR Renovacor, Inc. | D To issuer deriv | 2022-12-01 | 2022-12-05 | 10,936 | — | $0 | 0 | SEC↗ |
| RCOR Renovacor, Inc. | A Award | 2022-12-01 | 2022-12-05 | 4,329 | — | $0 | 4,329 | SEC↗ |
| RCOR Renovacor, Inc. | D To issuer | 2022-12-01 | 2022-12-05 | 4,329 | — | $0 | 0 | SEC↗ |
| RCOR Renovacor, Inc. | D To issuer | 2022-12-01 | 2022-12-05 | 18,800 | — | $0 | 0 | SEC↗ |
| SWKH SWK Holdings Corp | A Award | 2022-09-30 | 2022-10-04 | 809 | $17.00 | $13.8K | 4,283 | SEC↗ |
| SWKH SWK Holdings Corp | A Award | 2022-09-30 | 2022-10-04 | 1,162 | $17.00 | $19.8K | 3,474 | SEC↗ |
| SWKH SWK Holdings Corp | A Award | 2022-06-30 | 2022-07-05 | 1,137 | $17.47 | $19.9K | 2,312 | SEC↗ |
| RCOR Renovacor, Inc. | A Award deriv | 2022-06-17 | 2022-06-21 | 155,325 | — | $0 | 155,325 | SEC↗ |
| SWKH SWK Holdings Corp | A Award | 2022-03-31 | 2022-04-04 | 1,175 | $16.88 | $19.8K | 1,175 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2022-02-09 | 2022-02-11 | 3,000 | — | $0 | 3,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2022-02-09 | 2022-02-11 | 11,000 | — | $0 | 11,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2022-02-09 | 2022-02-11 | 2,500 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2022-02-09 | 2022-02-11 | 2,500 | — | $0 | 4,400 | SEC↗ |
| RCOR Renovacor, Inc. | A Award deriv | 2022-01-24 | 2022-01-26 | 37,575 | — | $0 | 37,575 | SEC↗ |
| RCOR Renovacor, Inc. | A Award | 2022-01-24 | 2022-01-26 | 18,800 | — | $0 | 23,129 | SEC↗ |
| RCOR Renovacor, Inc. | A Award deriv | 2021-09-03 | 2021-09-08 | 14,553 | — | $0 | 14,553 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2021-06-22 | 2021-06-23 | 2,500 | — | $0 | 2,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2021-06-22 | 2021-06-23 | 11,000 | — | $0 | 11,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise deriv | 2021-02-28 | 2021-03-02 | 1,900 | — | $0 | 0 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | M Exercise | 2021-02-28 | 2021-03-02 | 1,900 | — | $0 | 1,900 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2020-02-28 | 2020-03-03 | 19,000 | — | $0 | 19,000 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2020-02-28 | 2020-03-03 | 33,500 | — | $0 | 33,500 | SEC↗ |
| EYPT EyePoint Pharmaceuticals, | A Award deriv | 2019-07-15 | 2019-07-16 | 80,000 | — | $0 | 80,000 | SEC↗ |
| IIVI II-VI INC | M Exercise deriv | 2017-04-28 | 2017-04-28 | 2,500 | — | $0 | 17,500 | SEC↗ |
| IIVI II-VI INC | M Exercise | 2017-04-28 | 2017-04-28 | 2,500 | $15.42 | $38.5K | 33,046 | SEC↗ |
| IIVI II-VI INC | S Sale | 2017-04-28 | 2017-04-28 | 2,500 | $33.19 | $83.0K | 30,546 | SEC↗ |
| IIVI II-VI INC | M Exercise deriv | 2017-01-31 | 2017-02-01 | 3,000 | — | $0 | 0 | SEC↗ |
| IIVI II-VI INC | S Sale | 2017-01-31 | 2017-02-01 | 3,000 | $36.33 | $109.0K | 30,546 | SEC↗ |
| IIVI II-VI INC | M Exercise | 2017-01-31 | 2017-02-01 | 3,000 | $15.98 | $47.9K | 33,546 | SEC↗ |
| IIVI II-VI INC | S Sale | 2016-12-23 | 2016-12-27 | 4,400 | $29.36 | $129.2K | 30,546 | SEC↗ |
| IIVI II-VI INC | M Exercise deriv | 2016-09-08 | 2016-09-09 | 4,000 | — | $0 | 7,400 | SEC↗ |
| IIVI II-VI INC | S Sale | 2016-09-08 | 2016-09-09 | 4,000 | $22.30 | $89.2K | 34,946 | SEC↗ |
| IIVI II-VI INC | M Exercise | 2016-09-08 | 2016-09-09 | 4,000 | $15.98 | $63.9K | 38,946 | SEC↗ |
| IIVI II-VI INC | A Award deriv | 2016-08-20 | 2016-08-23 | 9,240 | — | $0 | 9,240 | SEC↗ |
| IIVI II-VI INC | A Award | 2016-08-20 | 2016-08-23 | 3,696 | $21.67 | $80.1K | 34,946 | SEC↗ |
| IIVI II-VI INC | M Exercise deriv | 2016-03-30 | 2016-03-30 | 2,000 | — | $0 | 11,400 | SEC↗ |
| IIVI II-VI INC | S Sale | 2016-03-30 | 2016-03-30 | 2,000 | $21.16 | $42.3K | 31,250 | SEC↗ |
| IIVI II-VI INC | M Exercise | 2016-03-30 | 2016-03-30 | 2,000 | $15.98 | $32.0K | 33,250 | SEC↗ |
| IIVI II-VI INC | A Award deriv | 2015-08-15 | 2015-08-18 | 8,970 | — | $0 | 8,970 | SEC↗ |
| IIVI II-VI INC | A Award | 2015-08-15 | 2015-08-18 | 4,485 | $17.84 | $80.0K | 31,250 | SEC↗ |
| GDHC CANNAPHARMARX, INC. | A Award deriv | 2015-02-27 | 2015-03-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| IIVI II-VI INC | A Award deriv | 2014-08-16 | 2014-08-19 | 11,440 | — | $0 | 11,440 | SEC↗ |
| IIVI II-VI INC | A Award | 2014-08-16 | 2014-08-19 | 5,720 | — | $0 | 26,765 | SEC↗ |
| IIVI II-VI INC | A Award deriv | 2013-08-17 | 2013-08-20 | 8,270 | — | $0 | 8,270 | SEC↗ |
| IIVI II-VI INC | A Award | 2013-08-17 | 2013-08-20 | 4,135 | — | $0 | 21,045 | SEC↗ |
| IIVI II-VI INC | A Award deriv | 2012-08-18 | 2012-08-21 | 8,620 | — | $0 | 8,620 | SEC↗ |
| IIVI II-VI INC | A Award | 2012-08-18 | 2012-08-21 | 4,310 | — | $0 | 16,910 | SEC↗ |